NaturallanguageprocessingDrugregulationTransparencyResponsibilityPharmacovigilanceBlackboxmodelsPatientrecruitmentPalantirConfidentialityBreakthroughsGeorgeWashingtonBloodlettingDisproportionalityanalysisIBMWatsonIdentitytheftPenicillinRaresideeffectsMedicalcodingPhase1RadioactivehazardAccidentaldiscoveryHumanoversightFairnessTrustEfficacyDecisionfatigueEfficiencyEvidencebasedAntifreezeThalidomideCIOMSPrivacypolicyDataheterogeneityPatientsafetySulfanilamideDataprivacyEMACaseprocessingAddictionBalancedpartnershipOpioidcrisisClinicaltrialsFinancialburdenSafetydatabasesDrug-inducedliver injuryLongtermsafetyRisk-basedapproachAIintegrationLifecyclegovernanceInterpretabilityPharmBERTHumorsGlobalharmonisationSafetyOuraRingPharmaceuticalsRadithorTraditionTragediesHIPAAPublictrustBiasFDAInnovationvs cautionSignaldetectionDemographicsInnovationOxycontinOverdosePatientforumsFutureimplicationsCybersecurityRealworlddataWearabletechToxiccompoundAskFDALabelDuplicatedetectionUnsaferecommendationsNaturallanguageprocessingDrugregulationTransparencyResponsibilityPharmacovigilanceBlackboxmodelsPatientrecruitmentPalantirConfidentialityBreakthroughsGeorgeWashingtonBloodlettingDisproportionalityanalysisIBMWatsonIdentitytheftPenicillinRaresideeffectsMedicalcodingPhase1RadioactivehazardAccidentaldiscoveryHumanoversightFairnessTrustEfficacyDecisionfatigueEfficiencyEvidencebasedAntifreezeThalidomideCIOMSPrivacypolicyDataheterogeneityPatientsafetySulfanilamideDataprivacyEMACaseprocessingAddictionBalancedpartnershipOpioidcrisisClinicaltrialsFinancialburdenSafetydatabasesDrug-inducedliver injuryLongtermsafetyRisk-basedapproachAIintegrationLifecyclegovernanceInterpretabilityPharmBERTHumorsGlobalharmonisationSafetyOuraRingPharmaceuticalsRadithorTraditionTragediesHIPAAPublictrustBiasFDAInnovationvs cautionSignaldetectionDemographicsInnovationOxycontinOverdosePatientforumsFutureimplicationsCybersecurityRealworlddataWearabletechToxiccompoundAskFDALabelDuplicatedetectionUnsaferecommendations

BIEN4110 - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
  1. Natural language processing
  2. Drug regulation
  3. Transparency
  4. Responsibility
  5. Pharmacovigilance
  6. Black box models
  7. Patient recruitment
  8. Palantir
  9. Confidentiality
  10. Breakthroughs
  11. George Washington
  12. Bloodletting
  13. Disproportionality analysis
  14. IBM Watson
  15. Identity theft
  16. Penicillin
  17. Rare side effects
  18. Medical coding
  19. Phase 1
  20. Radioactive hazard
  21. Accidental discovery
  22. Human oversight
  23. Fairness
  24. Trust
  25. Efficacy
  26. Decision fatigue
  27. Efficiency
  28. Evidencebased
  29. Antifreeze
  30. Thalidomide
  31. CIOMS
  32. Privacy policy
  33. Data heterogeneity
  34. Patient safety
  35. Sulfanilamide
  36. Data privacy
  37. EMA
  38. Case processing
  39. Addiction
  40. Balanced partnership
  41. Opioid crisis
  42. Clinical trials
  43. Financial burden
  44. Safety databases
  45. Drug-induced liver injury
  46. Longterm safety
  47. Risk-based approach
  48. AI integration
  49. Lifecycle governance
  50. Interpretability
  51. PharmBERT
  52. Humors
  53. Global harmonisation
  54. Safety
  55. Oura Ring
  56. Pharmaceuticals
  57. Radithor
  58. Tradition
  59. Tragedies
  60. HIPAA
  61. Public trust
  62. Bias
  63. FDA
  64. Innovation vs caution
  65. Signal detection
  66. Demographics
  67. Innovation
  68. Oxycontin
  69. Overdose
  70. Patient forums
  71. Future implications
  72. Cybersecurity
  73. Realworld data
  74. Wearable tech
  75. Toxic compound
  76. AskFDALabel
  77. Duplicate detection
  78. Unsafe recommendations